Issue 10
May. 2023
Turn off MathJax
Article Contents
JOURNAL OF MECHANICAL ENGINEERING  > 2023  >  44(10): 463-468.
LUO Zhan, CHEN Lei. Research Progress of Molecular Pathogenic Mechanism and Nutritional Intervention of Gut Microbiome[J]. Science and Technology of Food Industry, 2023, 44(10): 463−468. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022090055
Citation: LUO Zhan, CHEN Lei. Research Progress of Molecular Pathogenic Mechanism and Nutritional Intervention of Gut Microbiome[J]. Science and Technology of Food Industry, 2023, 44(10): 463−468. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022090055
shu

Research Progress of Molecular Pathogenic Mechanism and Nutritional Intervention of Gut Microbiome

doi: 10.13386/j.issn1002-0306.2022090055

  • School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, China

  • Received Date: 08 Sep 2022
  • Issue Publish Date: 15 May 2023
    Abstract
  • Changes in the abundance and types of gut microbiome can lead to diseases, and many basic and nervous system diseases have been confirmed to be related to gut microbiome. Exploring the molecular pathogenic mechanism of gut microbiome is the basis of directed regulation of gut microbiome to cure diseases. In this review, four molecular pathogenic mechanisms, including metabolic disorder caused by functional gene difference in gut microbiome, inflammatory cascade caused by proinflammatory factors, immune cell differentiation mediated by flora, and brain gut axis affecting brain activity are summarized. A "top-down" research approach, beginning with association analysis to molecular mechanism investigation is proposed, and nutritional intervention strategies developed for the corresponding pathogenic mechanisms are also summarized. In the future, the pathogenic mechanism of gut microbiome can be further studied employing the "top-down" approach, and nutritional intervention can be carried out more accurately basing on the relative pathogenic mechanism.

     

    • FullText(HTML)
  • loading
    • References(69)
  • [1]
    BÄCKHED F, LEY R E, SONNENBURG J L, et al. Host-bacterial mutualism in the human intestine[J]. Science,2005,307(5717):1915−1920. doi: 10.1126/science.1104816
    [2]
    METWALY A, REITMEIER S, HALLER D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders[J]. Nat Rev Gastroenterol Hepatol,2022,19(6):383−397. doi: 10.1038/s41575-022-00581-2
    [3]
    XU X, OCANSEY D K W, HANG S, et al. The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease[J]. Gut Pathog,2022,14(1):26. doi: 10.1186/s13099-022-00499-9
    [4]
    CANI P D, DEPOMMIER C, DERRIEN M, et al. Akkermansia muciniphila: Paradigm for next-generation beneficial microorganisms[J]. Nat Rev Gastroenterol Hepatol,2022(10):625−637.
    [5]
    ZHAO L, ZHANG F, DING X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J]. Science,2018,359(6380):1151−1156. doi: 10.1126/science.aao5774
    [6]
    IVANOV II, TUGANBAEV T, SKELLY A N, et al. T cell responses to the microbiota[J]. Annu Rev Immunol,2022,40:559−587. doi: 10.1146/annurev-immunol-101320-011829
    [7]
    PEREZ-PARDO P, DODIYA H B, ENGEN P A, et al. Role of TLR4 in the gut-brain axis in Parkinson's disease: A translational study from men to mice[J]. Gut,2019,68(5):829−843. doi: 10.1136/gutjnl-2018-316844
    [8]
    TAN A H, LIM S Y, LANG A E. The microbiome-gut-brain axis in Parkinson disease-from basic research to the clinic[J]. Nat Rev Neurol,2022,18(8):476−495. doi: 10.1038/s41582-022-00681-2
    [9]
    BISGAARD T H, ALLIN K H, KEEFER L, et al. Depression and anxiety in inflammatory bowel disease: Epidemiology, mechanisms and treatment[J]. Nat Rev Gastroenterol Hepatol,2022,19(11):717−726. doi: 10.1038/s41575-022-00634-6
    [10]
    WALTER J, ARMET A M, FINLAY B B, et al. Establishing or exaggerating causality for the gut microbiome: Lessons from human microbiota-associated rodents[J]. Cell,2020,180(2):221−232. doi: 10.1016/j.cell.2019.12.025
    [11]
    ZHAO L, ZHAO N. Demonstration of causality: Back to cultures[J]. Nat Rev Gastroenterol Hepatol,2021,18(2):97−98. doi: 10.1038/s41575-020-00400-6
    [12]
    HOU Y, WEI W, GUAN X, et al. A diet-microbial metabolism feedforward loop modulates intestinal stem cell renewal in the stressed gut[J]. Nat Commun,2021,12(1):271. doi: 10.1038/s41467-020-20673-4
    [13]
    ZHANG L, YUE Y, SHI M, et al. Dietary Luffa cylindrica (L.) Roem promotes branched-chain amino acid catabolism in the circulation system via gut microbiota in diet-induced obese mice[J]. Food Chem,2020,320:126648. doi: 10.1016/j.foodchem.2020.126648
    [14]
    VIOLI F, CAMMISOTTO V, BARTIMOCCIA S, et al. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease[J]. Nat Rev Cardiol, 2022: 1-14.
    [15]
    TURPIN W, DONG M, SASSON G, et al. Mediterranean-like dietary pattern associations with gut microbiome composition and subclinical gastrointestinal inflammation[J]. Gastroenterology,2022,163(3):685−698. doi: 10.1053/j.gastro.2022.05.037
    [16]
    YAO S, ZHANG M, DONG S S, et al. Bidirectional two-sample Mendelian randomization analysis identifies causal associations between relative carbohydrate intake and depression [J]. Nat Hum Behav, 2022,6(11):1569-1576.
    [17]
    FEI N, ZHAO L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice[J]. Isme J,2013,7(4):880−884. doi: 10.1038/ismej.2012.153
    [18]
    BLACHER E, BASHIARDES S, SHAPIRO H, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice[J]. Nature,2019,572(7770):474−480. doi: 10.1038/s41586-019-1443-5
    [19]
    SIDO B, HACK V, HOCHLEHNERT A, et al. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease[J]. Gut,1998,42(4):485−492. doi: 10.1136/gut.42.4.485
    [20]
    CHENG M, ZHAO Y, CUI Y, et al. Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis[J]. Ann Rheum Dis, 2022,81(12):1669-1677.
    [21]
    FEI N, BRUNEAU A, ZHANG X, et al. Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease[J]. mBio,2020,11(1):e03263−19.
    [22]
    LAMAS B, RICHARD M L, LEDUCQ V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands[J]. Nat Med,2016,22(6):598−605. doi: 10.1038/nm.4102
    [23]
    SROUR B, KORDAHI M C, BONAZZI E, et al. Ultra-processed foods and human health: From epidemiological evidence to mechanistic insights[J]. Lancet Gastroenterol Hepatol,2022,S2468-1253(22):00169−8.
    [24]
    ECKBURG P B, BIK E M, BERNSTEIN C N, et al. Diversity of the human intestinal microbial flora[J]. Science,2005,308(5728):1635−1638. doi: 10.1126/science.1110591
    [25]
    PRYDE S E, DUNCAN S H, HOLD G L, et al. The microbiology of butyrate formation in the human colon[J]. FEMS Microbiol Lett,2002,217(2):133−139. doi: 10.1111/j.1574-6968.2002.tb11467.x
    [26]
    LOOMBA R, SANYAL A J. The global NAFLD epidemic[J]. Nat Rev Gastroenterol Hepatol,2013,10(11):686−690. doi: 10.1038/nrgastro.2013.171
    [27]
    LI J, CASANOVA J L, PUEL A. Mucocutaneous IL-17 immunity in mice and humans: Host defense vs. excessive inflammation[J]. Mucosal Immunol,2018,11(3):581−589. doi: 10.1038/mi.2017.97
    [28]
    OKADA S, MARKLE J G, DEENICK E K, et al. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations[J]. Science,2015,349(6248):606−613. doi: 10.1126/science.aaa4282
    [29]
    HONDA K, LITTMAN D R. The microbiota in adaptive immune homeostasis and disease[J]. Nature,2016,535(7610):75−84. doi: 10.1038/nature18848
    [30]
    KAWANO Y, EDWARDS M, HUANG Y, et al. Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome[J]. Cell,2022,185(19):3501−3519. doi: 10.1016/j.cell.2022.08.005
    [31]
    GOTO Y, PANEA C, NAKATO G, et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation[J]. Immunity,2014,40(4):594−607. doi: 10.1016/j.immuni.2014.03.005
    [32]
    YANG Y, TORCHINSKY M B, GOBERT M, et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens[J]. Nature,2014,510(7503):152−156. doi: 10.1038/nature13279
    [33]
    ATARASHI K, TANOUE T, ANDO M, et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells[J]. Cell,2015,163(2):367−380. doi: 10.1016/j.cell.2015.08.058
    [34]
    SANO T, HUANG W, HALL J A, et al. An IL-23R/IL-22 circuit regulates epithelial serum amyloid a to promote local effector Th17 responses[J]. Cell,2015,163(2):381−393. doi: 10.1016/j.cell.2015.08.061
    [35]
    LEE J Y, HALL J A, KROEHLING L, et al. Serum amyloid a proteins induce pathogenic th17 cells and promote inflammatory disease[J]. Cell,2020,180(1):79−91. doi: 10.1016/j.cell.2019.11.026
    [36]
    ZHOU W, ZHOU L, ZHOU J, et al. ZBTB46 defines and regulates ILC3s that protect the intestine[J]. Nature,2022,609(7925):159−165. doi: 10.1038/s41586-022-04934-4
    [37]
    GRIGG J B, SHANMUGAVADIVU A, REGEN T, et al. Antigen-presenting innate lymphoid cells orchestrate neuroinflammation[J]. Nature,2021,600(7890):707−712. doi: 10.1038/s41586-021-04136-4
    [38]
    ZHANG M, CHU Y, MENG Q, et al. A quasi-paired cohort strategy reveals the impaired detoxifying function of microbes in the gut of autistic children[J]. Sci Adv,2020,6(43):eaba3760. doi: 10.1126/sciadv.aba3760
    [39]
    SHARON G, CRUZ N J, KANG D W, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice[J]. Cell,2019,177(6):1600−1618. doi: 10.1016/j.cell.2019.05.004
    [40]
    LIU Y, YANG M, TANG L, et al. TLR4 regulates RORγt(+) regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila[J]. Microbiome,2022,10(1):98. doi: 10.1186/s40168-022-01296-x
    [41]
    ZHANG J H, XIN H L, XU Y M, et al. Morinda officinalis How. —A comprehensive review of traditional uses, phytochemistry and pharmacology[J]. J Ethnopharmacol,2018,213:230−255. doi: 10.1016/j.jep.2017.10.028
    [42]
    CHI L, CHEN L, ZHANG J, et al. Development and application of bio-sample quantification to evaluate stability and pharmacokinetics of inulin-type fructo-oligosaccharides from Morinda officinalis[J]. J Pharm Biomed Anal,2018,156:125−132. doi: 10.1016/j.jpba.2018.04.028
    [43]
    ZHANG Z W, GAO C S, ZHANG H, et al. Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota[J]. Acta Pharm Sin B,2022,12(8):3298−3312. doi: 10.1016/j.apsb.2022.02.032
    [44]
    HUANG F, ZHENG X, MA X, et al. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism[J]. Nat Commun,2019,10(1):4971. doi: 10.1038/s41467-019-12896-x
    [45]
    BOLTE L A, VICH VILA A, IMHANN F, et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome[J]. Gut,2021,70(7):1287−1298. doi: 10.1136/gutjnl-2020-322670
    [46]
    KE S, WEISS S T, LIU Y Y. Rejuvenating the human gut microbiome[J]. Trends Mol Med,2022,28(8):619−630. doi: 10.1016/j.molmed.2022.05.005
    [47]
    CHEN D, WU J, JIN D, et al. Fecal microbiota transplantation in cancer management: Current status and perspectives[J]. Int J Cancer,2019,145(8):2021−2031. doi: 10.1002/ijc.32003
    [48]
    KEDIA S, VIRMANI S, S K V, et al. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: A randomised controlled trial[J]. Gut, 2022,71(12):2401-2413.
    [49]
    FEDERICI S, KREDO-RUSSO S, VALDéS-MAS R, et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation[J]. Cell,2022,185(16):2879−2898. doi: 10.1016/j.cell.2022.07.003
    [50]
    TANG S, CHEN Y, DENG F, et al. Xylooligosaccharide-mediated gut microbiota enhances gut barrier and modulates gut immunity associated with alterations of biological processes in a pig model[J]. Carbohydr Polym,2022,294:119776. doi: 10.1016/j.carbpol.2022.119776
    [51]
    HE X Q, LIU D, LIU H Y, et al. Prevention of ulcerative colitis in mice by sweet tea (Lithocarpus litseifolius) via the regulation of gut microbiota and butyric-acid-mediated anti-inflammatory signaling[J]. Nutrients,2022,14(11):2208. doi: 10.3390/nu14112208
    [52]
    ZHAO Y, JIANG Q. Roles of the polyphenol-gut microbiota interaction in alleviating colitis and preventing colitis-associated colorectal cancer[J]. Adv Nutr,2021,12(2):546−565. doi: 10.1093/advances/nmaa104
    [53]
    PANDEY K B, RIZVI S I. Plant polyphenols as dietary antioxidants in human health and disease[J]. Oxid Med Cell Longev,2009,2(5):270−278. doi: 10.4161/oxim.2.5.9498
    [54]
    CANTU-JUNGLES T M, BULUT N, CHAMBRY E, et al. Dietary fiber hierarchical specificity: The missing link for predictable and strong shifts in gut bacterial communities[J]. mBio,2021,12(3):e0102821. doi: 10.1128/mBio.01028-21
    [55]
    ZHANG X, MONNOYE M, MARIADASSOU M, et al. Glucose but not fructose alters the intestinal paracellular permeability in association with gut inflammation and dysbiosis in mice[J]. Front Immunol,2021,12:742584. doi: 10.3389/fimmu.2021.742584
    [56]
    MARTEL J, CHANG S H, KO Y F, et al. Gut barrier disruption and chronic disease[J]. Trends Endocrinol Metab,2022,33(4):247−265. doi: 10.1016/j.tem.2022.01.002
    [57]
    KOSINSKA A, ANDLAUER W. Modulation of tight junction integrity by food components[J]. Food Research International,2013,54(1):951−960. doi: 10.1016/j.foodres.2012.12.038
    [58]
    AMASHEH M, FROMM A, KRUG S M, et al. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling[J]. J Cell Sci, 2010, 123(Pt 23): 4145-4155.
    [59]
    SUZUKI T, HARA H. Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in caco-2 cells[J]. J Nutr,2009,139(5):965−974. doi: 10.3945/jn.108.100867
    [60]
    MAYANGSARI Y, SUZUKI T. Resveratrol ameliorates intestinal barrier defects and inflammation in colitic mice and intestinal cells[J]. J Agric Food Chem,2018,66(48):12666−12674. doi: 10.1021/acs.jafc.8b04138
    [61]
    CANI P D, BIBILONI R, KNAUF C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice[J]. Diabetes,2008,57(6):1470−1481. doi: 10.2337/db07-1403
    [62]
    DONG L, XIE J, WANG Y, et al. Mannose ameliorates experimental colitis by protecting intestinal barrier integrity[J]. Nat Commun,2022,13(1):4804. doi: 10.1038/s41467-022-32505-8
    [63]
    BAE M, CASSILLY C D, LIU X, et al. Akkermansia muciniphila phospholipid induces homeostatic immune responses[J]. Nature,2022,608(7921):168−173. doi: 10.1038/s41586-022-04985-7
    [64]
    BELKAID Y, HARRISON O J. Homeostatic immunity and the microbiota[J]. Immunity,2017,46(4):562−576. doi: 10.1016/j.immuni.2017.04.008
    [65]
    ANSALDO E, BELKAID Y. How microbiota improve immunotherapy[J]. Science,2021,373(6558):966−967. doi: 10.1126/science.abl3656
    [66]
    BEUKEMA M, JERMENDI É, OERLEMANS M M P, et al. The level and distribution of methyl-esters influence the impact of pectin on intestinal T cells, microbiota, and Ahr activation[J]. Carbohydr Polym,2022,286:119280. doi: 10.1016/j.carbpol.2022.119280
    [67]
    TCHITCHEK N, NGUEKAP TCHOUMBA O, PIRES G, et al. Low-dose interleukin-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation[J]. JCI Insight,2022,7(17):e159406. doi: 10.1172/jci.insight.159406
    [68]
    JENSEN S N, CADY N M, SHAHI S K, et al. Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis[J]. Sci Adv,2021,7(28):eabd4595. doi: 10.1126/sciadv.abd4595
    [69]
    EZRA-NEVO G, HENRIQUES S F, RIBEIRO C. The diet-microbiome tango: How nutrients lead the gut brain axis[J]. Curr Opin Neurobiol,2020,62:122−132. doi: 10.1016/j.conb.2020.02.005
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views(29) PDF downloads(0) Cited by()
    Proportional views
    Related

    Copyright © 2009《 石油钻探技术 》 All Rights Reserved.

    Address：North-Star Times Tower, No.8 Beichendong Road, Chaoyang District, Beijing, China China Pos：100101

    Tel：010-84988317，84988356，84988357 Fax：021-64253812 Email：syzt@vip.163.com

    Beijing public network security equipment 11010502036328　Beijing ICP backup 17033152

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return